SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BioSepra (BSEP) -- Biotech Supplier Play -- Ignore unavailable to you. Want to Upgrade?


To: Gary Vanier who wrote (10)11/16/1997 3:41:00 PM
From: Ed Ajootian  Read Replies (1) | Respond to of 20
 
Gary,

I had far too high expectations for this company and thought it would turn profitable a lot sooner. I only have a tiny amount left and don't really follow it any more.

My only source of info. was reports plus a few phone conversations with the president, Jean-Marie Vogel. He is reasonably approachable. These guys do not get a lot of phone calls from shareholders so when you call, as long as they are not really busy, they will get back to you.

They have a tough row to hoe since they are so small and the drug companies only want to do business with strong, solid companies that they know will be around 5 years from now.

Good luck!



To: Gary Vanier who wrote (10)3/8/1998 7:24:00 PM
From: Ed Ajootian  Read Replies (1) | Respond to of 20
 
Gary,

Wondering if you ever took the plunge on this one and what you found in your due diligence. The stock is starting to show signs of life and the 1st quarter report may just be a doozy.

Friday's action was up $.125 to $1.875 on 62,000 shares, 10 X normal volume.

I'm seriously considering jumping back in if I can sneak in for under $2.

I have seen the future and the future is MONOCLONAL ANTIBODIES!